Plakous Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Debt
- (Announced)
- Latest Deal Amount
-
$12M
- Investors
-
5
Plakous Therapeutics General Information
Description
Developer of placenta-powered biotherapeutics designed to generate multiple products for regenerative healing. The company utilizes the placenta disc with allografts, treats the amniotic membrane to improve its functionality as a drug delivery device, and allows for the local delivery of drugs, enabling healthcare companies and patients to avail themselves of healing products engineered with scientific rigor and clinical efficacy.
Contact Information
Website
www.plakoustherapeutics.comCorporate Office
- 755 Highland Oaks Drive
- Suite 103
- Winston-Salem, NC 27103
- United States
Corporate Office
- 755 Highland Oaks Drive
- Suite 103
- Winston-Salem, NC 27103
- United States
Plakous Therapeutics Timeline
Plakous Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Debt - General | 01-Jun-2023 | $12M | Announced | Generating Revenue | ||
| 11. Later Stage VC | 30-Jun-2023 | Completed | Generating Revenue | |||
| 10. Grant | 30-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 05-Jul-2022 | Completed | Pre-Clinical Trials | |||
| 8. Grant | 10-Aug-2021 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Aug-2021 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC | 09-Jul-2020 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 02-Jul-2020 | Completed | Pre-Clinical Trials | |||
| 4. Angel (individual) | 24-Jan-2020 | $780K | $1.41M | Completed | Pre-Clinical Trials | |
| 3. Seed Round | 28-Mar-2018 | $500K | $625K | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Plakous Therapeutics Comparisons
Industry
Financing
Details
Plakous Therapeutics Competitors (8)
One of Plakous Therapeutics’s 8 competitors is Neurona Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Amplicore | Venture Capital-Backed | Mason, OH | ||||
| Noveome Biotherapeutics | Venture Capital-Backed | Pittsburgh, PA | ||||
| Xalud Therapeutics | Venture Capital-Backed | New York, NY | ||||
| CalciMedica | Formerly VC-backed | La Jolla, CA |
Plakous Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Plakous Therapeutics Patents
Plakous Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022341205-A1 | Acellular placental therapies | Pending | 07-Sep-2021 | ||
| CA-3230944-A1 | Acellular placental therapies | Pending | 07-Sep-2021 | ||
| EP-4398888-A1 | Acellular placental therapies | Inactive | 07-Sep-2021 | ||
| US-20240374651-A1 | Acellular placental therapies | Pending | 07-Sep-2021 | ||
| US-20240374652-A1 | Acellular placental therapies | Pending | 07-Sep-2021 | A61K35/50 |
Plakous Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Plakous Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CH Innovations | Not-For-Profit Venture Capital | Minority | ||
| Altis Biosystems | VC-Backed Company | |||
| North Carolina Biotechnology Center | Not-For-Profit Venture Capital | Minority | ||
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Government | |||
| NIH Office of the Director | Government |
Plakous Therapeutics FAQs
-
When was Plakous Therapeutics founded?
Plakous Therapeutics was founded in 2015.
-
Where is Plakous Therapeutics headquartered?
Plakous Therapeutics is headquartered in Winston-Salem, NC.
-
What is the size of Plakous Therapeutics?
Plakous Therapeutics has 8 total employees.
-
What industry is Plakous Therapeutics in?
Plakous Therapeutics’s primary industry is Drug Discovery.
-
Is Plakous Therapeutics a private or public company?
Plakous Therapeutics is a Private company.
-
What is Plakous Therapeutics’s current revenue?
The current revenue for Plakous Therapeutics is .
-
How much funding has Plakous Therapeutics raised over time?
Plakous Therapeutics has raised $5.41M.
-
Who are Plakous Therapeutics’s investors?
CH Innovations, Altis Biosystems, North Carolina Biotechnology Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and NIH Office of the Director have invested in Plakous Therapeutics.
-
Who are Plakous Therapeutics’s competitors?
Neurona Therapeutics, Amplicore, Noveome Biotherapeutics, Xalud Therapeutics, and CalciMedica are some of the 8 competitors of Plakous Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
